TomoTherapy Incorporated Earnings Conference Call (Q1 2008) Today's Calls 
Visit the TF Network Sites
Visit the TF Network Sites
· Corporate IR Center
· Institutional Investor Center
· Individual Investor Center
Download Plug-In
Real Player 8 Basic
Windows Media Player
Other Conference Calls
Other Apr 28 Calls
Today's Calls
Call Details
TomoTherapy Incorporated Earnings Conference Call (Q1 2008)
Mon, Apr 28, 2008, 5:00 pm Eastern

Listen to the archived event audio


About TomoTherapy Incorporated (NasdaqGS:TOMO)Other Calls 
TomoTherapy Incorporated develops, markets, and sells the Hi Art system, a radiation therapy system for the treatment of various types of cancers. The Hi Art system combines integrated CT imaging with radiation therapy to deliver radiation treatment while reducing radiation exposure to surrounding healthy tissue. The Hi Art system contains a linear accelerator, a device that generates external beam radiation that is used both to capture images and to deliver therapeutic radiation to selected targets in a helical, or spiral, delivery pattern 360 degrees around the body. It markets the Hi Art system to university research centers, community hospitals, private and governmental institutions, and cancer care centers in North America, Europe, the Middle East, and the Asia-Pacific, through direct sales personnel, sales agents, and distributors. The company was founded in 1997 and is headquartered in Madison, Wisconsin.


More Info: Quote | Chart | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings


Copyright © 2008 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Copyright © 2008 FirstCall Events. Historical chart data provided by Commodity Systems, Inc. (CSI). Company profile information presented on this page is Copyright Capital IQ. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.